Sano Genetics | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights
Sano Genetics is a biotechnology research company based in Cambridge, England, focused on accelerating the transition to precision...
Sano Genetics is a biotechnology research company based in Cambridge, England, focused on accelerating the transition to precision medicine. The company offers an end-to-end precision medicine platform that integrates genetic testing, recruitment, and long-term patient engagement, streamlining clinical operations and enhancing the efficiency of clinical trials.
Website
Headquarters
Cambridge, England
Size
51-200 employees
Industry
Biotechnology Research
Specialities
Genetics, Big Data, Research
ποΈ Sano Genetics Product and Pricing News β
π Sano Genetics CEO, Management and Leadership Team β
βοΈ Sano Genetics Alternatives and Competitors β
πΌ Sano Genetics Hiring and Layoffs β
π€ Sano Genetics Developer, Integration and Automation News β
π Sano Genetics Financials, Fundraising and Valuation News β
ποΈ Sano Genetics Product and Pricing News
- Sano Genetics' 'Light the Way' platform now includes education opportunities alongside research connections for ALS patients and families.
- Sano Genetics will be in San Francisco next week to discuss genomics advancements and partnership opportunities at the JPMorgan Healthcare Conference.
- Patrick Short and Benjamin Jackson from Sano Genetics will be in San Francisco next week to discuss healthcare innovations.
- Sano Genetics won the Pharma Supplier of the Year award at the Pharma Industry Awards UK 2024.
- Charlotte Guzzo, Co-founder and COO of Sano Genetics, is mentioned as a speaker at the Tech.eu Summit London 2025.
- Sano Genetics is hosting a casual get-together at the American Society of Human Genetics event in Denver to celebrate over 150 episodes of The Genetics Podcast.
- Sano Genetics has been named in Bloomberg UK's Startups to Watch 2024 and announced a new partnership to enhance specialist eye care and research in the USA.
- Sano Genetics has been named one of Bloomberg's Startups to Watch 2024, highlighting their innovation and diversity.
π Sano Genetics CEO, Management and Leadership Team
-
Vice President of Neuroscience[email protected]
-
Co-Founder and CEO[email protected]
-
CTO and Cofounder[email protected]
-
Founder and COO[email protected]
βοΈ Sano Genetics Alternatives and Competitors
- Akkure |
- Invitae |
- PreventionGenetics |
- Phase Genomics |
- Arima Genomics |
- 10x Genomics |
- Helix |
- Geneticure |
- Eugene |
- MedySapiens |
- Molecular You |
- SITraN |
- Cellartis |
- Fios Genomics |
- Glasgow Precision Oncology Laboratory |
- Renovacor |
- Eikon Therapeutics |
- Interius BioTherapeutics |
- Dermavant Sciences |
- Metrum Research Group |
- Clovis Oncology
πΌ Sano Genetics Hiring and Layoffs
- Miguel Da Silva has left Sano Genetics, where he served as Global Talent Acquisition Lead, to join Salience Labs as Head of People & Talent Acquisition in the Greater Oxford Area.
- Lindsey Wahlstrom-Edwards has been appointed as Head of Patient Engagement and Strategic Partnerships at Sano Genetics.
- Sandra BlΓ€ser has left Sano Genetics, where she served as VP Customer Success & Delivery, Patient Recruitment & Engagement in Ireland, to join Causaly as Principal - Strategic Engagement EMEA.
- Benjamin Jackson has joined Sano Genetics as VP of Commercial in the United States, previously serving as Executive Vice President, Commercial at BC Platforms.
- Paul Wicks, Vice President of Neuroscience at Sano Genetics, emphasized the importance of UK participants benefiting from promising drug research.
- Urma Cox has left Sano Genetics, where she was part of the Marketing Team in the United Kingdom, to join Evolve Academy Ltd as a Trainee Hairstylist.
- Mitchell Pease joined Sano Genetics in Q1 2024 to help advance precision medicine studies.
- Rory Wilkinson has left Sano Genetics as a Business Development Representative to join Diaceutics PLC as a Key Account Manager in the United Kingdom.
π€ Sano Genetics Developer, Integration and Automation News
- Sano Genetics is partnering with Glanzmann's Research Foundation and Hemab Therapeutics to conduct a survey on the daily life impacts of Glanzmann Thrombasthenia.
- Sano Genetics partners with Neuron23 to streamline patient referrals and provide genetic testing and counseling for the NEULARK clinical trial in early Parkinson's disease.
- Sano Genetics partners with Lifebit and Lupus Research to establish DREAM, a secure data platform for lupus research and treatments.
- Sano Genetics is collaborating with the Lupus Research Alliance to enhance patient engagement in the DREAM platform by enabling lupus patients to participate in research and access their data.
- Sano Genetics is supporting a research program with Prevail Therapeutics to provide free at-home genetic testing and counseling for frontotemporal dementia (FTD).